Adam Mendelsohn

Adam Mendelsohn, Ph.D. is Co-Founder & Chief Executive Officer of Vivani Medical, an emerging biopharmaceutical company developing a pipeline of miniature, long-term drug implants with its proprietary NanoPortal™ platform technology for obesity/weight management and other chronic diseases.

Posts by Adam Mendelsohn

MedCity Influencers

The Role of Medication Delivery in Non-Adherence

For GLP-1 receptor agonists specifically, adherence challenges are a major concern, as these medications require long-term use to achieve meaningful health benefits in chronic conditions like diabetes and obesity.

Adam Mendelsohn

Posts by Adam Mendelsohn

The Role of Medication Delivery in Non-Adherence

Move Over Doximity — There’s a New Social Network for Doctors

Axsome Drug’s FDA Approval Unlocks New Opportunity in Alzheimer’s Agitation

Why Clinical Digital Out-of-Home Displays Are Healthcare’s Most Untapped Advertising Opportunity